Dimitra Manou Selected Research

serglycin

5/2020	Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential.
1/2020	Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.
12/2018	Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dimitra Manou Research Topics

Disease

4	Neoplasms (Cancer) 05/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 06/2022 - 12/2018
1	Brain Neoplasms (Brain Tumor) 05/2020
1	Glioblastoma (Glioblastoma Multiforme) 05/2020
1	Carcinogenesis 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Disease Progression 01/2020
1	Pathologic Processes 01/2018

Drug/Important Bio-Agent (IBA)

3	serglycinIBA 05/2020 - 12/2018
2	Pharmaceutical PreparationsIBA 06/2022 - 01/2018
2	Proteoglycans (Proteoglycan)IBA 01/2020 - 12/2018
1	Fluorouracil (Carac)FDA LinkGeneric 06/2022
1	Chalcone (Benzalacetophenone)IBA 06/2022
1	Estrogens (Estrogen)FDA Link 06/2022
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Estrogen ReceptorsIBA 12/2018
1	Interleukin-8 (Interleukin 8)IBA 12/2018
1	ChemokinesIBA 12/2018
1	ZincIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	EndopeptidasesIBA 01/2018
1	Matrix Metalloproteinase InhibitorsIBA 01/2018

Therapy/Procedure

1	Therapeutics 06/2022